Changes in serum lipids in patients with rheumatoid arthritis treated with a combination of tocilizumab and methotrexate compared with methotrexate alone for 24 weeks of observation

Changes in serum lipids in patients with rheumatoid arthritis treated with a combination of tocilizumab and methotrexate compared with methotrexate alone for 24 weeks of observation

Show other versions (1)

<p class="p1"><span class="s1">Background. According to the some studies tocilizumab therapy (TCZ) in patients with rheumatoid arthritis (RA) is accompanied by deterioration of blood lipid profile.<br /> Aim. To study changes in serum lipid parameters in patient...

Full description

Bibliographic Details
Main Authors: E. V. Udachkina, D. S. Novikova, T. V. Popkova, E. Yu. Panasyuk, A. S. Avdeeva, A. V. Volkov, I. G. Kirillova, E. I. Markelova, E. N. Aleksandrova, A. A. Novikov, E. L. Nasonov
Format: Article
Language:English
Published: Столичная издательская компания 2015-11-01
Series:Рациональная фармакотерапия в кардиологии
Subjects:
ревматоидный артрит
тоцилизумаб
метотрексат
липиды
статины
Online Access:http://www.rpcardio.ru/jour/article/view/325

Internet

http://www.rpcardio.ru/jour/article/view/325

Similar Items